期刊文献+

脑钠肽水平在慢性阻塞性肺疾病急性加重期和左心功能不全患者中的临床意义 被引量:4

The clinical significance of serum brain natriuretic peptide in patients with acute exacerbation of chronic obstructive pulmonary disease and patients with left ventricular dysfunction
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)急性加重期和左心功能不全患者血浆中脑钠肽(BNP)水平和临床意义。方法住院治疗的55例左心功能不全患者和COPD患者,在其入院时测得BNP水平,进行相关性分析。结果左心功能不全患者BNP水平明显高于COPD患者(P<0.01);BNP浓度与第一秒钟用力呼气容积(FEV1)/预计值百分比呈负相关(r=-0.868,P<0.01);BNP浓度与LVEF之间呈负相关(r=-0.929,P<0.01);BNP>200 pg/ml时左心功能不全患者数目大于COPD患者。结论左心功能不全的患者BNP水平明显高于COPD急性加重期患者,BNP能帮助鉴别COPD急性加重期与左心功能不全。 Objective To study the clinical significance of serun brain natriuretic peptide change in patients with acute exacerbation of chronic obstructive pulmonary disease and patients with left ventricular dysfunction. Methods Retrospective medical records analysis of all patients hospitalized from January 2008 to May 2011 with the final diagnosis of acute exacerbation of COPD and left ventricular dysfunction, and who had undergone serum BNP test at admission. Results The serum BNP levels in patients with left ventricular dysfunction was significantly higher than patients with COPD (P 〈 0.01 ). BNP levels were negatively correlated with FEV1 (% of predicted value, r = -0.868 ,P 〈0.001 ). BNP levels were negatively correlated with LVEF(r = -0. 868 ,P 〈0.001 ). BNP 〉 200pg/ml, the number of patients with left ventricular dysfunction was greater than that of patients with COPD. Conclusion The serun BNP detection can help physicians in identifying heart failure in patients suffering from an acute exacerbation of COPD.
作者 刘辉 徐晓玲
出处 《中国临床保健杂志》 CAS 2013年第3期263-265,I0002,共4页 Chinese Journal of Clinical Healthcare
关键词 肺疾病 慢性阻塞性 心室功能障碍 利钠肽 Pulmonary disease, chronic obstructive Ventricular dysfunction, left Natriuretic peptide, brain
  • 相关文献

参考文献8

  • 1Runen FH, Cramer M J, Lainmers JW, et al. Heart failure and chronic obstructive pulmonary disease: An ignored combination? [J]. Eur J Heart Fail, 2006,8 ( 7 ) : 706- 711.
  • 2Rutten FH, Moons KG, Cramer MJ, et al. Recognising heart failure in elderly patients with stable chronic ob- structive pulmonary disease in primary care:cross section- al diagnostic study [ J ]. BMJ, 2005,331 (7529) : 1379.
  • 3Havranek EP, Masoudi FA, Wesffall KA, et al. Spectrum of heart failure in older patients:results from the National Heart Failure project [ J ]. Am Heart J, 2002, 143 ( 3 ) : 412-417.
  • 4Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary dis- ease, Saskatchewan Canada cardiovascular disease in COPD patients [ J ]. Ann Epidemiol, 2006,16 ( 1 ) : 63-70.
  • 5Braunstein JB, Anderson GF, Gerstenblith G, et al. Non- cardiac comorbidity increase preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure [ J ]. J Am Coil Cardiol, 2003,42 ( 7 ) : 1226-1233.
  • 6Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and thera- peutic challenges in patients with coexistent chronic ob- structive pulmonary disease and chronic heart failure [ J ]. J Am Coll Cardiol,2007,49(2) :171-180.
  • 7Palazzuoli A, Antonelli G, Quatrini I, et al. Natriuretic peptides in heart failure:where we are, where we are going[ J]. Intern Emerg Med,2011,6( 1 ) ,63-68.
  • 8Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergen- cy diagnosis of heart failure[ J]. N Engl J Med,2002,347 (3) :161-167.

同被引文献63

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部